Customs (Prohibited Imports) Regulations (Amendment)

Legislation au C1953L00056 Regulations Not in force Legislative Instrument

Legislation content

STATUTORY RULES.

1953.  No. 56

REGULATIONS UNDER THE CUSTOMS ACT 1901-1952.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Customs Act 1901-1952.

Dated this   Twenty fifth

day of  June  , 1953.

W J. SLIM

Governor-General.

By His Excellency's Command,

Minister of State for Shipping and Transport for and
on behalf of Minister of State for Trade and Customs

AMENDMENTS OF THE CUSTOMS (PROHIBITED IMPORTS) REGULATIONS.

First Schedule.

1. The First Schedule to the Customs (Prohibited Imports) Regulations is amended by inserting after item 13 the following item:—

“14

Diacetylmorphine, its salts and preparations containing diacetylmorphine or its salts ".

Third Schedule.

2. The Third Schedule to the Customs (Prohibited Imports) Regulations is amended—

(a) by omitting paragraph (d) from the second column of item 4A and inserting in its stead the following paragraph:—

" (d) esters of morphine and their salts, other than diacetylmorphine and its salts; ";

(b) by omitting from paragraph (r) in the second column of item 4A the words " the substances referred to in subparagraph (ii) of paragraph (d) or in paragraph (e),(f), (g), (j) or (k)" and inserting in their stead the words "the substances specified in paragraph (d), (e), (f), (g), (j) or (k)"; and

(c) by inserting after item 12A the following item:—

" 12B

Thyroid

The goods shall be accompanied by a certificate, signed by or on behalf of the exporter of the goods, certifying that the goods conform with the standard required by the British Pharmacopoeia”.

* Notified in the Commonwealth Gazette on                                                                       , 1953.

Statutory Rules 1934, No. 152, as amended to date. For previous Customs  (Prohibited Imports) Regulations see footnote t to Statutory Rules 1943, No. 11 ; and see also Statutory Rules 1945, Nos. 34 and 144 ; 1946, Nos. 59, 77 and 169 ; 1947, Nos. 66, 81, 119 and 164 ; 1948. Nos. 35 and 145 ; 1949. Nos. 18, 87 and 94 ; 1951, Nos. 5, 75 and 141 ; 1952, No. 114 ; and 1953, No. 10.

_________________________

By Authority: L. F. JOHNSTON, Commonwealth Government Printer, Canberra.

1558.—PRICE 3D. 10/30.3.1953.

Overview

Statutory Rules 1953 No. 56, Regulations under the Customs Act 1901-1952, was enacted to amend the Customs (Prohibited Imports) Regulations by introducing new restrictions on the importation of specific substances. The Regulations were made by the Governor-General in Council under the authority granted by the Customs Act 1901-1952. The problem or gap these Regulations sought to address was the need to more stringently control the importation of dangerous and controlled substances, particularly narcotics. The policy objective, as evidenced in the Regulations, is to prevent the illegal importation of these substances into Australia, thereby protecting public health and safety.

Scope and Application

These Regulations under the Customs Act 1901-1952, specifically amending the Customs (Prohibited Imports) Regulations, apply to the prohibition of certain imports into the Commonwealth of Australia. The primary focus of these amendments is the regulation of controlled substances, particularly narcotics, and specific medical products like thyroid goods. This legislation applies to all entities involved in the importation of goods into Australia, including individuals and corporations, and extends to the entire national jurisdiction of the Commonwealth of Australia. The scope of these regulations includes the prohibition of items such as diacetylmorphine and its salts, alongside amendments clarifying the inclusion of esters of morphine and their salts, and introducing requirements for thyroid goods to be accompanied by a certificate of conformity with the British Pharmacopoeia. The exclusions and thresholds in these regulations are set to ensure the safety and compliance of imported goods with national health and safety standards. Additionally, the application of these regulations can be extended or restricted through subordinate instruments as needed.

Key Provisions

The Customs (Prohibited Imports) Regulations, amended by Statutory Rules 1953 No. 56, introduce significant changes to the scope of prohibited imports under the Customs Act 1901-1952. Firstly, item 14 has been added to the First Schedule (1) of the Regulations, prohibiting the import of diacetylmorphine, its salts, and any preparations containing these substances. This addition is intended to strengthen the regulatory framework around narcotics by specifically targeting a potent opioid. Secondly, the Third Schedule (2) is amended in several ways, including the reclassification and clarification of certain substances under the morphine category. Notably, esters of morphine and their salts are now specified in a new paragraph (d) in the second column of item 4A, while the references to other substances within item 4A have been adjusted to ensure clarity and accuracy. Entities and individuals governed by these Regulations are obligated to comply with the updated list of prohibited and regulated substances. Specifically, they must ensure that any imported goods do not contain the newly listed diacetylmorphine, its salts, or preparations thereof. Additionally, any imports of thyroid goods must be accompanied by a certificate signed by the exporter, attesting to the conformity of the goods with the standards set by the British Pharmacopoeia (1). This certification process is critical to verifying the quality and safety of imported medical substances. Failure to comply with these regulations can lead to serious consequences. Unauthorized imports of prohibited substances, such as diacetylmorphine, could result in criminal charges under the Customs Act. The penalties for such offences can include substantial fines and imprisonment. For instance, the importation of controlled substances without proper certification may attract penalties that are commensurate with the severity of the breach, reflecting the stringent regulatory environment concerning dangerous drugs and medical products. The precise penalties are not detailed in the statutory rules but would typically align with those stipulated in the overarching Customs Act.

Legal classification tags

Area of Law
Customs & Excise Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Prohibited Conduct
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.